Changes in smell and taste perception related to COVID-19 infection: a case-control study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 05 2022
Historique:
received: 13 01 2022
accepted: 22 04 2022
entrez: 17 5 2022
pubmed: 18 5 2022
medline: 21 5 2022
Statut: epublish

Résumé

The main aim of the present study was to psychophysically evaluate smell and taste functions in hospitalized COVID-19 patients and to compare those results with a group of healthy subjects. Another aim of the study was to assess the relationship of changes in patients' smell and taste functions with a number of clinical parameters, symptoms, and other physiological signs as well as with severity of disease. Olfactory and gustatory functions were tested in 61 hospitalized patients positive for SARS-CoV-2 infection and in a control group of 54 healthy individuals. Overall, we found a significant impairment of olfactory and gustatory functions in COVID-19 patients compared with the control group. Indeed, about 45% of patients self-reported complaints about or loss of either olfactory or gustatory functions. These results were confirmed by psychophysical testing, which showed a significantly reduced performance in terms of intensity perception and identification ability for both taste and smell functions in COVID-19 patients. Furthermore, gustatory and olfactory impairments tended to be more evident in male patients suffering from more severe respiratory failure (i.e., pneumonia with need of respiratory support need during hospitalization).

Identifiants

pubmed: 35581235
doi: 10.1038/s41598-022-11864-8
pii: 10.1038/s41598-022-11864-8
pmc: PMC9112641
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8192

Informations de copyright

© 2022. The Author(s).

Références

Jotz, G. P., Voegels, R. L. & Bento, R. F. Otorhinolaryngologists and coronavirus disease 2019 (COVID-19). Int. Arch. Otorhinolaryngol. 24(02), 1158 (2020).
Parma, V. et al. More than smell—COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem. Sens. 45(7), 609–622 (2020).
doi: 10.1093/chemse/bjaa041
Santos, R. E. A. et al. Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: A systematic review. Am. J. Otolaryngol. 102889, 2225 (2021).
Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581(7807), 215–220 (2020).
pubmed: 32225176 doi: 10.1038/s41586-020-2180-5
Glezer, I., Bruni-Cardoso, A., Schechtman, D. & Malnic, B. Viral infection and smell loss: The case of COVID-19. J. Neurochem. 157(4), 930–943 (2021).
pubmed: 32970861 doi: 10.1111/jnc.15197
Hawkes, C. H. Smell, taste and COVID-19: Testing is essential. QJM 114(2), 83–91 (2021).
pubmed: 33340323 doi: 10.1093/qjmed/hcaa326
Cazzolla, A. P. et al. Taste and smell disorders in COVID-19 patients: Role of interleukin-6. ACS Chem. Neurosci. 11(17), 2774–2781 (2020).
pubmed: 32786309 doi: 10.1021/acschemneuro.0c00447
Brann, D. H. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 6(31), 5801 (2020).
doi: 10.1126/sciadv.abc5801
Huart, C. et al. Comparison of COVID-19 and common cold chemosensory dysfunction. Rhinology 58(6), 623–625 (2020).
pubmed: 32812014 doi: 10.4193/Rhin20.251
Giacomelli, A. et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: A cross-sectional study. Clin. Infect. Dis. 71(15), 889–890 (2020).
pubmed: 32215618 doi: 10.1093/cid/ciaa330
Chico-García, J. L. et al. Acute-onset smell and taste disorders in the context of COVID-19: A pilot multicentre polymerase chain reaction based case–control study. Eur. J. Neurol. 27(9), 1738–1741 (2020).
pubmed: 32320508 doi: 10.1111/ene.14273
Lechien, J. R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur. Arch. Otorhinolaryngol. 277(8), 2251–2261 (2020).
pubmed: 32253535 pmcid: 7134551 doi: 10.1007/s00405-020-05965-1
Niklassen, A. S. et al. COVID-19: Recovery from chemosensory dysfunction. A multicentre study on smell and taste. Laryngoscope. 131(5), 1095–1100 (2021).
pubmed: 33404079 doi: 10.1002/lary.29383
Hannum, M. E. et al. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19–positive patients compared to subjective methods: A systematic review and meta-analysis. Chem. Sens. 45(9), 865–874 (2020).
Cao, A. C. et al. Objective screening for olfactory and gustatory dysfunction during the COVID-19 pandemic: A prospective study in healthcare workers using self-administered testing. World J. Otorhinolaryngol. Head Neck Surg. https://doi.org/10.1016/j.wjorl.2021.02.001 (2021).
doi: 10.1016/j.wjorl.2021.02.001 pubmed: 33614178
Hintschich, C. A. et al. Psychophysical tests reveal impaired olfaction but preserved gustation in COVID-19 patients. Int. Forum Allergy Rhinol. https://doi.org/10.1002/alr.22655 (2020).
doi: 10.1002/alr.22655 pubmed: 32613712 pmcid: 7362102
Hornuss, D. et al. Anosmia in COVID-19 patients. Clin. Microbiol. Infect. 26(10), 1426–1427 (2020).
pubmed: 32447049 pmcid: 7242197 doi: 10.1016/j.cmi.2020.05.017
Iravani, B. et al. Relationship between odor intensity estimates and COVID-19 population prediction in a Swedish sample. Chem. Sens. 45(6), 449–456 (2020).
doi: 10.1093/chemse/bjaa034
Le Bon, S. D. et al. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell. Eur. Arch. Oto-Rhino-Laryngol. 278(8), 3113–3117 (2021).
doi: 10.1007/s00405-020-06520-8
Moein, S. T., Hashemian, S. M., Tabarsi, P. & Doty, R. L. Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients. Int. Forum Allergy Rhinol. 10(10), 1127–1135 (2020).
pubmed: 32761796 doi: 10.1002/alr.22680
Vaira, L. A. et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 42(6), 1252–1258 (2020).
pubmed: 32342566 pmcid: 7267244 doi: 10.1002/hed.26204
Vaira, L. A. et al. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck. 42(7), 1560–1569 (2020).
pubmed: 32437022 doi: 10.1002/hed.26269
Vaira, L. A. et al. Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine. Head Neck. 42(7), 1570–1576 (2020).
pubmed: 32357379 doi: 10.1002/hed.26228
Villerabel, C. et al. Diagnostic value of patient-reported and clinically tested olfactory dysfunction in a population screened for COVID-19. JAMA Otolaryngol. Head Neck Surg. 147(3), 271–279 (2021).
pubmed: 33410887 doi: 10.1001/jamaoto.2020.5074
Landis, B. N., Hummel, T., Hugentobler, M., Giger, R. & Lacroix, J. S. Ratings of overall olfactory function. Chem. Sens. 28(8), 691–694 (2003).
doi: 10.1093/chemse/bjg061
Lötsch, J. & Hummel, T. Clinical usefulness of self-rated olfactory performance—a data science-based assessment of 6000 patients. Chem. Sens. 44(6), 357–364 (2019).
doi: 10.1093/chemse/bjz029
Altin, F., Cingi, C., Uzun, T. & Bal, C. Olfactory and gustatory abnormalities in COVID-19 cases. Eur. Arch. Otorhinolaryngol. 277(10), 2775–2781 (2020).
pubmed: 32577902 pmcid: 7309687 doi: 10.1007/s00405-020-06155-9
Gözen, E. D. et al. Evaluation of olfactory function with objective tests in COVID-19-positive patients: A cross-sectional study. Ear Nose Throat. J. 100(2), 169S-173S (2021).
pubmed: 33236918 pmcid: 7689254 doi: 10.1177/0145561320975510
Mazzatenta, A. et al. Smell and taste in severe CoViD-19: Self-reported vs. testing. Front. Med. 7, 11058 (2020).
doi: 10.3389/fmed.2020.589409
Moein, S. T. et al. Smell dysfunction: A biomarker for COVID-19. Int. Forum Allergy Rhinol. 10(8), 944–950 (2020).
pubmed: 32301284 doi: 10.1002/alr.22587
Paderno, A. et al. Smell and taste alterations in Covid-19: A cross-sectional analysis of different cohorts. Int. Forum Allergy Rhinol. 10(8), 955–962 (2020).
pubmed: 32410386 doi: 10.1002/alr.22610
Cattaneo, C., Riso, P., Laureati, M., Gargari, G. & Pagliarini, E. Exploring associations between interindividual differences in taste perception, oral microbiota composition, and reported food intake. Nutrients 11(5), 1167 (2019).
pmcid: 6567015 doi: 10.3390/nu11051167
Proserpio, C., Laureati, M., Bertoli, S., Battezzati, A. & Pagliarini, E. Determinants of obesity in Italian adults: The role of taste sensitivity, food liking, and food neophobia. Chem. Sens. 41(2), 169–176 (2016).
Cattaneo, C., Mameli, C., D’Auria, E., Zuccotti, G. & Pagliarini, E. The influence of common noncommunicable diseases on chemosensory perception and clinical implications in children and adolescents. Adv. Nutr. 13(1), 234–247 (2022).
pubmed: 34535793 doi: 10.1093/advances/nmab100
Xu, H. et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral. Sci. 12(1), 1–5 (2020).
doi: 10.1038/s41368-020-0074-x
Mastrangelo, A., Bonato, M. & Cinque, P. Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes. Neurosci Lett. 748, 135694 (2021).
pubmed: 33600902 pmcid: 7883672 doi: 10.1016/j.neulet.2021.135694
Burges Watson, D. L. et al. Altered smell and taste: Anosmia, parosmia and the impact of long Covid-19. PLoS ONE 16(9), e0256998 (2021).
pubmed: 34559820 pmcid: 8462678 doi: 10.1371/journal.pone.0256998
Santos, D. V., Reiter, E. R., DiNardo, L. J. & Costanzo, R. M. Hazardous events associated with impaired olfactory function. Arch. Otolaryngol. Head Neck Surg. 130(3), 317–319 (2004).
pubmed: 15023839 doi: 10.1001/archotol.130.3.317
Croy, I., Nordin, S. & Hummel, T. Olfactory disorders and quality of life—an updated review. Chem. Sens. 39(3), 185–194 (2014).
doi: 10.1093/chemse/bjt072
Parker, J. K., Kelly, C., Smith, B., Hopkins, C. & Gane, S. An analysis of patients’ perspectives on qualitative olfactory dysfunction using social media. medRxiv. 11, 11589 (2021).
Liu, D. T., Welge-Lüssen, A., Besser, G., Mueller, C. A. & Renner, B. Assessment of odor hedonic perception: The Sniffin’sticks parosmia test (SSParoT). Sci. Rep. 10(1), 1–14 (2020).
Pellegrino, R., Mainland, J. D., Kelly, C. E., Parker, J. K. & Hummel, T. Prevalence and correlates of parosmia and phantosmia among smell disorders. Chem. Sens. 46, 11047 (2021).
doi: 10.1093/chemse/bjab046
Landis, B. N., Frasnelli, J. & Hummel, T. Euosmia: A rare form of parosmia. Acta Otolaryngol. 126(1), 101–103 (2006).
pubmed: 16308262 doi: 10.1080/00016480510043954
Parker, J. K., Kelly, C. E., & Gane, S. B. Molecular mechanism of parosmia. medRxiv. (2021).
Wysocki, C. J. & Gilbert, A. N. National geographic smell survey: Effects of age are heterogenous. Ann. N. Y. Acad. Sci. 561, 12–28 (1989).
pubmed: 2735671 doi: 10.1111/j.1749-6632.1989.tb20966.x
Wysocki, C. J. & Pelchat, M. L. The effects of aging on the human sense of smell and its relationship to food choice. Crit. Rev. Food Sci. Nutr. 33(1), 63–82 (1993).
pubmed: 8424856 doi: 10.1080/10408399309527613
Joussain, P. et al. Application of the European test of olfactory capabilities in patients with olfactory impairment. Eur. Arch. Otorhinolaryngol. 273(2), 381–390 (2016).
pubmed: 25711735 doi: 10.1007/s00405-015-3536-6
Maremmani, C. et al. The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson’s disease patients. Parkinsonism Relat. Disord. 18(6), 788–793 (2012).
pubmed: 22510205 doi: 10.1016/j.parkreldis.2012.03.021
Hummel, T., Sekinger, B., Wolf, S. R., Pauli, E. & Kobal, G. ‘Sniffin’sticks’: Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem. Sens. 22(1), 39–52 (1997).
doi: 10.1093/chemse/22.1.39
Richards, P. M., Johnson, E. C. & Silver, W. L. Four irritating odorants target the trigeminal chemoreceptor TRPA1. Chemosens. Percept. 3(3–4), 190–199 (2010).
doi: 10.1007/s12078-010-9081-1
Weyer-Menkhoff, I. & Lötsch, J. Human pharmacological approaches to TRP- ion-channel-based analgesic drug development. Drug Discov. Today. 23(12), 2003–2012 (2018).
pubmed: 29969684 doi: 10.1016/j.drudis.2018.06.020
Licon, C. C., Manesse, C., Dantec, M., Fournel, A. & Bensafi, M. Pleasantness and trigeminal sensations as salient dimensions in organizing the semantic and physiological spaces of odors. Sci. Rep. 8(1), 1–12 (2018).
doi: 10.1038/s41598-018-26510-5
Piochi, M., Dinnella, C., Spinelli, S., Monteleone, E. & Torri, L. Individual differences in responsiveness to oral sensations and odours with chemesthetic activity: Relationships between sensory modalities and impact on the hedonic response. Food Qual. Prefer. 88, 104112 (2021).
doi: 10.1016/j.foodqual.2020.104112
Monteleone, E. et al. Exploring influences on food choice in a large population sample: The Italian Taste project. Food Qual. Prefer. 59, 123–140 (2017).
doi: 10.1016/j.foodqual.2017.02.013
Chamoun, E. et al. Taste sensitivity and taste preference measures are correlated in healthy young adults. Chem. Sens. 44(2), 129–134 (2019).
doi: 10.1093/chemse/bjy082

Auteurs

Camilla Cattaneo (C)

Sensory & Consumer Science Lab (SCS_Lab), Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, 20133, Milan, Italy.

Ella Pagliarini (E)

Sensory & Consumer Science Lab (SCS_Lab), Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, 20133, Milan, Italy. ella.pagliarini@unimi.it.

Sara Paola Mambrini (SP)

International Center for the Assessment of Nutritional Status (ICANS), Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, 20133, Milan, Italy.
Laboratory of Metabolic Research, San Giuseppe Hospital, IRCCS Istituto Auxologico Italiano, 28824, Piancavallo, Italy.

Elena Tortorici (E)

Department of Cardiovascular Neural and Metabolic Sciences, San Luca Hospital, IRCCS Istituto Auxologico Italiano, 20149, Milan, Italy.

Roberto Mené (R)

Department of Medicine and Surgery, University of Milano-Bicocca, 20126, Milan, Italy.

Camilla Torlasco (C)

Department of Cardiovascular Neural and Metabolic Sciences, San Luca Hospital, IRCCS Istituto Auxologico Italiano, 20149, Milan, Italy.

Elisa Perger (E)

Department of Medicine and Surgery, University of Milano-Bicocca, 20126, Milan, Italy.
Sleep Disorders Center and Department of Cardiology, San Luca Hospital, IRCCS Istituto Auxologico Italiano, 20149, Milan, Italy.

Gianfranco Parati (G)

Department of Medicine and Surgery, University of Milano-Bicocca, 20126, Milan, Italy.
Sleep Disorders Center and Department of Cardiology, San Luca Hospital, IRCCS Istituto Auxologico Italiano, 20149, Milan, Italy.

Simona Bertoli (S)

International Center for the Assessment of Nutritional Status (ICANS), Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, 20133, Milan, Italy.
Obesity Unit - Laboratory of Nutrition and Obesity Research, Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, 20145, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH